University of Pennsylvania

ScholarlyCommons
Center for Bioethics Papers

Center for Bioethics

12-28-2010

The Queering of HIV Testing Practices and the Reinforcement of
Stigma
Lance Wahlert
University of Pennsylvania, wahlert@sas.upenn.edu

Autumn Fiester
University of Pennsylvania, fiester@mail.med.upenn.edu

Follow this and additional works at: https://repository.upenn.edu/bioethics_papers
Part of the Medicine and Health Sciences Commons

Recommended Citation
Wahlert, L., & Fiester, A. (2010). The Queering of HIV Testing Practices and the Reinforcement of Stigma.
Retrieved from https://repository.upenn.edu/bioethics_papers/70

Suggested Citation:
Wahlert, L. and Fiester, A. “Re-Queering HIV Testing Practices and the Reinforcement of Stigma,” American Journal
of Bioethics, Volume 11, No. 4, April 2011: 41-43.
Preprint version.
This is an electronic version of an article published in American Journal of Bioethics. American Journal of
Bioethics is available online at: http://www.tandfonline.com/doi/abs/10.1080/15265161.2011.560356.
This paper is posted at ScholarlyCommons. https://repository.upenn.edu/bioethics_papers/70
For more information, please contact repository@pobox.upenn.edu.

The Queering of HIV Testing Practices and the Reinforcement of Stigma
Disciplines
Medicine and Health Sciences

Comments
Suggested Citation:
Wahlert, L. and Fiester, A. “Re-Queering HIV Testing Practices and the Reinforcement of Stigma,”
American Journal of Bioethics, Volume 11, No. 4, April 2011: 41-43.
Preprint version.
This is an electronic version of an article published in American Journal of Bioethics. American Journal of
Bioethics is available online at: http://www.tandfonline.com/doi/abs/10.1080/15265161.2011.560356.

This journal article is available at ScholarlyCommons: https://repository.upenn.edu/bioethics_papers/70

“The Queering of HIV Testing Practices and the Reinforcement of Stigma”
by Lance Wahlert and Autumn Fiester

Present-day practices and protocols on the standards for HIV-testing with regard
to matters such as informed consent, opt-out clauses, and counseling services owe their
existence to 1990s policies on how to test gay-male and anonymous blood samples for
the HIV virus. Nearly 25 years ago, the burden on clinicians and ethicists when testing
persons for HIV was this: “What services are we obliged to provide these persons in
exchange for letting us test their blood samples for HIV?” Accordingly, we guaranteed
them the right to know their sero-status, confidentiality at all costs, and sexual health
counseling regardless of the results of their HIV tests so that their future health would be
improved.1
And now we have the most recent CDC policy, and the support of it by Celada et
al, that seems to have forgotten this ethical history.
Authors Celada et al. are highly supportive of the revised 2006 CDC guidelines
for HIV testing practices, arguing that the new policy-recommendations are ethically
sound and that the only ethical concerns raised by the policy would be their potentially
improper implementations. In a shallow and short-sighted ethical review devoid of
1

Several footnotes here from the journal HIV Counselor Perspectives (1999, 2002,
2006); as well as from FOCUS: On HIV Antibody Test Counseling (1993, 1999); and
“Ethics and Malpractice: AIDS & HIV Infection Update” which sites AIDS Health
Project 1989, IOM report of 1989, and Coates 1988 study on the ethics of AIDS antibody
testing at-large.
1

historiographical nuance, the authors view the CDC’s move to universalize HIV testing
as de-stigmatizing, because the so-called “high-risk” groups are no longer specifically
targeted. But the authors fail to recognize that the CDC’s ostensibly “de-queering” of
HIV testing is now coupled with a recommendation for queer-targeted prevention
counseling, indicating that the only population that puts the sero-negative general
population at risk is sero-positive queers, a spurious conclusion given that their own data
shows that 32% of new HIV infections resulted from high-risk heterosexual contact
(CDC 2009). The CDC’s recommendations that prevention counseling be provided only
to “persons at high risk for HIV” and only in settings “in which risk behaviors are
assessed” thereby reinforces how sexually dangerous they supposedly are – i.e., the STD
clinic – not only reinforce the societal stigma against gay men, but reveal the CDC’s own
inherent biases.
On the surface, the 2006 CDC policy looks ecumenical—a one-size-fits-all
approach that appears to universalize and, hence, de-stigmatize. Accordingly, the CDC’s
non-targeted testing looks non-discriminatory because it claims to treat all cases the same.
This is the interpretation of Celada et al, who, taking a strongly pro-CDC position, write:
“HIV-related stigma might decrease as HIV testing becomes accepted by society as
universal and routine and not perceived to be associated with particular at-risk groups”
(Celada et al. 2011, 10). But this is a very naïve use of the word “might”, one that
supposes a beneficial outcome without evidence, especially since this interpretation
focuses only on the testing-recommendations of the CDC policy, not on its broader
counseling-recommendation changes.
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In fact, the testing-recommendations are best understood not as “universalizing,”
but rather as “de-queering,” that is, no longer concentrated on the specific needs and
threats of queer populations (sero-positive or sero-negative). Does such a strategy really
improve the ethical justification of HIV-testing for queer and non-queer populations?
We argue that it does not, since, while the testing-recommendations take a “de-queering”
approach, the recommendations on prevention counseling utterly re-marginalize the queer
test-subject, exclusively targeting an already highly stigmatized group. In this regard, the
policy (despite its noble intentions) actually differentiates sharply among populations and,
therefore, re-stigmatizes high-risk groups (namely, gay men). Therefore, the supposedly
non-discriminatory CDC testing recommendations now come partnered with the
decoupling of prevention counseling, whereby there remains only targeted counseling of
queer persons who are being treated in certain settings, like the STD clinic. Consider the
following prose from the 2006 CDC report:
Prevention counseling should not be required as a part of the HIV screening
programs in health-care settings. Prevention counseling is strongly encouraged for
persons at high risk for HIV in settings in which risk behaviors are assessed
routinely (e.g., STD clinics) but should not have to be linked to HIV testing
(Branson et al. 2006, 11; quoted by Celada et al. 2011, 5).
Like the CDC, authors Celada et al view this new policy on prevention counseling as a
non-biased, data-driven decision. Following the CDC, Celada et al argue that prevention
counseling is of questionable benefit to most patients (the non-queer?) who are tested and,
ostensibly, only necessary in the queer-subgroup. This is a curious interpretation of the
existing data on the effectiveness of prevention counseling for both the sero-negative and
the sero-positive. Such a rationale is flawed on many counts. Are the “persons at high
risk for HIV” a clearly defined subset? If they are, does this not reveal clinical prejudice?
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And, perhaps most strikingly, if there is a clear “high risk” subset, is it not clinically and
ethically reckless for us to assume that there is no overlap sexually or otherwise between
such populations? Supposed “high-risk” persons (and queers, specifically) do not inhabit
a separate place nor live on a separate plane than the general population. The 2006 CDC
policy on HIV-testing, sadly, fails to realize this.
Before taking a closer look at data behind the CDC’s recent policy, it is worth
scrutinizing Celada et al’s troubling conclusion that if we don’t know definitively that
counseling is helpful, it is ethically unproblematic to omit it from clinical care. They
write, “In the absence of a definitive answer to questions about the value of providing
prevention counseling to all, and in the light of this practice serving as a deterrent to
widespread HIV screening, then the CDC’s recommendation is not ethically troubling”
(Celada et al. 2011, 20). On the contrary, if we are uncertain about whether an existing
intervention policy might be helpful in stopping the spread of a disease – especially one
where the stakes are as high as they are in the devastating AIDS epidemic – then we have
an ethical obligation to the public to find out whether the intervention is or is not
effective before such a service is discontinued. In fact, Celada et al (along with the CDC)
should be calling for more research if the data do not speak definitively on this question.
It is neither clear that counseling is a deterrent to widespread screening, nor that
counseling is ineffective in preventing the spread of the disease, therefore it is premature
to offer a verdict on the CDC recommendations as “not ethically troubling.”
Perhaps most problematic is the fact that there is data that prevention-counseling
is beneficial in both sero-negative and sero-positive patient populations, and the most
compelling data ironically comes from the CDC’s own earlier studies (Kamb et al 1998).
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Celada et al blindly follow the CDC’s new report, misrepresenting the very studies they
cite. Because much is made about the differences in the efficacy of counseling those who
test negative versus those who test positive (not to mention how we define “efficacy”),
we will look at the data on each group, starting with the seronegative.
Celada et al reaffirm the conclusions reached by the 2006 CDC report (Celada et
al 19), where the CDC concludes: “HIV counseling and testing as implemented in the
studies had little effect on HIV-negative participants” (Branson 2006). This conclusion
comes from a 1999 piece from the American Journal of Public Health, in which
Weinhardt’s meta-analysis (Weinhardt 1999) contradicts the findings of the CDC’s
Project RESPECT Study (intended to study the efficacy of HIV counseling prevention)
found that prevention counseling had a beneficial impact in sero-negative populations
(Kamb et al 1998). In fact, at that time the CDC immediately criticized the Weinhardt et
al study and cautioned against changing any recommendations based on it. But why?
The authors of the CDC RESPECT Study, in a letter to the editor in the issue of
American Journal of Public Health that published the Weinhardt study, argued that the
meta-analysis was flawed because it did not properly distinguish between more effective
modes of counseling from less effective ones (Kamb 2000). Similarly, in the Journal of
Infectious Disease in 2007, authors Holtgrave and McGuire (2007) analyzed the flaws of
the Weinhardt et al study, explaining that the study design made it impossible to judge
whether counseling was effective because it didn’t compare testing-alone to testing-withcounseling (there were two arms of the study: “counseling-plus-testing” and “no-testing,
no-counseling”). Holtgrave and McGuire drew the same conclusion that the CDC had in
2000, namely, that the RESPECT Study demonstrated the clear benefit of client-centered
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counseling for the seronegative (Holtgrave and McGuire 2007). What is most striking
about the 2006 CDC recommendations is that the Kamb et al study’s test population was
HIV-negative heterosexuals (Kamb et al 1998), the very population that will now receive
no prevention counseling on grounds that it is not beneficial. Queer stigma aside, then,
are we not doing a disservice to the entire HIV-testing population with the jettisoning of
counseling services?
When we turn to the issue of prevention counseling for sero-positive patients, the
current CDC recommendations seem downright bizarre. With sero-positive patients,
there isn’t even a controversy about the benefits of counseling, with Weinhardt et al
clearly stating, “HIV testing and counseling appears to provide an effective means of
secondary prevention for HIV-positive individuals” (1999, 1397). Citing this very study,
the 2006 CDC report draws the spurious conclusion that “[t]he benefit of providing
prevention counseling in conjunction with HIV testing is less clear” (Branson et al 2006).
With all of this data as the evidentiary backdrop for the new CDC policy, we are
skeptical that clinical effectiveness could really be the reason for the current
recommendations. And by turn, the ethics of the Celada et al article are also questionable.
In fact, such slash-and-burn cuts to HIV-testing and counseling policies from both parties
read more like the recommendations of budgetary panels, whereby expanded testing
mandates a curtailing of supplementary services from that testing. One is left to wonder:
Is cost efficiency (not clinical efficacy or medical ethics) the true motivation behind the
new targeted counseling recommendations? And yet, the cost of counseling seems to be
minimal (Holtgrave and McGuire 2007; Kamb et al 1998), and the CDC’s own press
release in 1998 argued that such counseling was at one time cost-effective (CDC 1998).
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If this is a new policy not about clinical efficacy or financial responsibility, as an
alternative interpretation of their rationale, we question whether there is an inherent and
invested queer bias at work here.
Before the 2006 policy revisions, the CDC recommendation was targeted testing
(which, of course, revealed its own bias) coupled with prevention-counseling. According
to ethical debates before 2006, the counseling provided to tested persons (especially those
in high-risk or confidential target-groups) was deemed an ethically necessary and humane
benefit in exchange for testing those who could be potentially stigmatized. In other
words, in exchange for being tested involuntarily or voluntarily (with a stealthily invoked
“opt-out” clause), our clinical duty was to repay such parties being tested with the
counseling and services to ensure their individual better health, if not the health of larger
populations. Has the ethical necessity of counseling tested parties expired? Is this based
on the naïve assumption that AIDS is now always a chronic, manageable disease (which
it is not)? And even if it were true that AIDS is always chronic, does this render obsolete
the obvious clinical and educational values of counseling persons who are tested for
HIV? Do we render persons worthy of counseling only when their test results might
result in a fatal diagnosis? What precedent does this set for how we test those with
diabetes, sickle cell anemia, Tay-Sachs disease, and hypertension, to name a few other
conditions? Most importantly, do we find permissible the elimination of universal
counseling for universal HIV testing (in the face of still asking for high-risk queers to be
counseled) because we really want to assuage our notions that there are not two different
kinds of HIV: queer and non-queer?
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Now that testing is no longer targeted but counseling is, the logic of this
methodology follows that being “eligible” for counseling is already to be placed in the
category of a “danger to society” because no others – sero-negative or sero-positive –
appear to need it. Only sero-negative and sero-positive queers are recommended to
receive counseling, and at a site (the STD clinic) where their supposed threat to society is
already proven by virtue of needing access that type of sexually-sensitive healthcare. If
this is the CDC’s view, then these queer individuals have shown themselves to be both
contagious and a threat to social well-being, by the very nature of their desires and sexual
practices. Accordingly, queers are always sick or potentially sick, so they are in need of
HIV prevention-counseling that others do not require. By contrast, all others – regardless
of sero-status or safe/safer/unsafe sexual activities – presumably need no counseling to
protect themselves or other people from HIV-transmission. The CDC’s conclusion seems
to be that in supposedly “safe” populations, there is no need for counseling to prevent the
spread of HIV, even though some of the members of that population may have just tested
positive. This is clinical and pathological naïveté of the highest order.
Celada et al admit that some will see some of these flaws – though they don’t
elaborate on or cite any adherents to these views. As an almost trivial after-thought, they
add: “Also, some worry that if prevention counseling is provided only to a select group of
patients, stigma about HIV testing might be increased” (Celada et al. 2011, 19). Invoking
another naïve use of the word “might,” Celada et al again propose optimistic conclusions
about their ethical justifications without considering the historical and contemporary
stakes of such claims. Indeed, there is good reason to believe that queer-targeted
counseling will absolutely re-stigmatize queer persons, since the policy-makers
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themselves – and their apologists like Celada et al – instinctively continue to see them as
truly dangerous and sero-differnent when they conveniently single them out. The new
CDC testing and counseling recommendations may aim to de-queer HIV testing policies,
but they do so without vested interest in the long-standing needs and sensitivities of the
queer persons themselves. As a result, the CDC (and Celada et al, by turn, in their ethical
treatise-cum-press-release for the CDC) merely reinforce stigma by marginalizing the
queer parties in question. If this is a fiduciary matter, one wishes all parties would just
say so. In the absence of that admission, parties tested for HIV (especially suspicious
queers) of the past 25 years who have contributed to such studies will remain skeptical
contributors to this epidemiological work. How are we serving the general public health?
How are we being rewarded for that service? How are we being served personally? And
in the cases of queers, how are we being pathologized, marginalized, and segregated even
when we test negative?
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